Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

World Awaits Biosimilars Boom

Published: Thursday, October 04, 2012
Last Updated: Wednesday, October 03, 2012
Bookmark and Share
Biosimilars set to take a sizable chunk of the global biopharmaceuticals market by 2020, new report predicts.

With an introduction to the US set for 2014, and the realization of massive potential in the emerging markets of Asia, biosimilars are set to take a sizable chunk of the global biopharmaceuticals market by 2020, predicts a new report by global business intelligence firm GBI Research.

According to the latest study, the massive potential for pharmaceuticals in the US means that the country’s biosimilars market could be valued at $9 billion by the end of the decade, despite the fact that they will only enter the market in 2014.

Similarly, the activities of major pharmaceutical companies such as Dr. Reddy’s will see the Indian biosimilars sector treble in value in just five years, from $482m in 2011 to $1.4 billion by 2016.

GBI Research notes that ‘pharmerging’ countries across Asia have attracted the interest of big biopharmaceutical players, with lenient regulations and tax incentives available during the initial industrial phase.

Already more than 20 biosimilar companies operate in India, with approximately 55 products in the market, while the State Food and Drug Administration (SFDA) in China had approved 40 biopharmaceutical products up until December 2011 - the majority of which were biosimilars.

South Korea has also on record as a committed industry advocate, with the Korean government announcing a target of achieving 22% of the global market share for biosimilars by 2015.

The global biopharmaceutical market was valued at $138 billion in 2011 and is expected to grow to over $320 billion by 2020. Roche dominated the global production of biopharmaceuticals last year, manufacturing 25% of the total.

Johnson & Johnson was second with a share of 8.8%, while Boehringer Ingleheim was the third largest manufacturer in the sector, holding an 8.5% share.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Global Biosimilars Market Value Could Hit $55 Billion by 2020, says GBI Research
Promising pipeline in active development and government efforts to reduce healthcare spending.
Thursday, July 02, 2015
Big Pharma Embraces Biologics
Increased uptake of biologics boosts API revenues and promote growth in the biopharmaceutical market.
Friday, November 30, 2012
Biologics and Stem Cell Research Boost the Cell Culture Market
Cell culture market expected to grow at a CAGR of 9.3% between 2011 and 2018.
Thursday, November 15, 2012
Outsourcing in Asia to Shrink Japan’s Revenue Share
Pharma’s interest in outsourcing, combined with rising industrialization in India and China, will mark a drop in Japan’s share of the continent’s revenue.
Tuesday, November 06, 2012
‘Tis the Season to Be Sniffly - Seasonal Influenza Boosts Vaccines Market
Acute viral respiratory infection influenza, or flu, strikes every winter, and several nations are preparing to tackle this illness through dedicated healthcare schemes, states a new report by healthcare experts GBI Research.
Monday, October 22, 2012
Innovation May Mean Collaborations for Drug Development in Future
Research collaborations and shared data will mark a change in the fiercely competitive pharmaceutical world, states a new report by healthcare experts GBI Research.
Wednesday, September 26, 2012
Struggling Pharma Companies to Outsource Clinical Trial Research
Falling revenue in some healthcare sectors means companies are making huge efforts to reduce R&D expenditure and increase profitability.
Monday, April 23, 2012
Cost of Antivirals for HIV/AIDS Set to Increase
Antiviral drugs become expensive due to the launch of new combination therapies.
Friday, April 06, 2012
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!